
Journal of Fluorine Chemistry p. 207 - 215 (1990)
Update date:2022-09-26
Topics:
Benomar, Salim
Patel, Bina
Tipping, Anthony E.
Treatment of the title azine (1) with phenyl-lithium results in initial replacement of chlorine by phenyl to give the monophenylazine (4) and then the diphenylazine (5), but this is followed by successive replacement of fluorine in one CF3 group to afford first the 3,4-diazahexa-1,3-diene CF3CPh2N=NCPh=CXY (6) (X=Y=F), then (7) (X=F, Y=Ph) and finally (8) (X=Y=Ph).
View MoreShandong united-rising pharmaceutical cooperation.,ltd.
Contact:008653187965009
Address:171No., Jing5 Road, Shizhong District, Jinan, China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Luzhou North Chemical Co., Ltd.
Contact:+86-830-2796784;+86-830-2796776
Address:Gaoba, Longmatan District, Luzhou, Sichuan Province
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Doi:10.1016/j.tetlet.2011.08.152
(2011)Doi:10.1016/0040-4020(95)00072-G
(1995)Doi:10.1021/jo00014a015
(1991)Doi:10.1016/S0020-1693(00)86774-2
(1990)Doi:10.1021/ic3021904
(2013)Doi:10.1021/jo00010a004
(1991)